[Cytotoxicity of antilymphocytic globulin on tumor cells synchronized in various phases of the cell cycle]. 1977

S Imperato, and F Manca, and A L Kunkl, and L Di Crescenzo, and A Gremmo

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000961 Antilymphocyte Serum Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION. ATGAM,Antilymphoblast Globulins,Antilymphocyte Antibodies,Antilymphocyte Globulin,Lymphocytotoxic Antibodies,Anti-Thymocyte Globulin,Antilymphocyte Immunoglobulin,Antithymocyte Globulin,Antithymoglobulin,Lymphocyte Immune Globulin, Anti-Thymocyte Globulin,Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine),Pressimmune,Anti Thymocyte Globulin,Anti-Thymocyte Globulins,Antibodies, Antilymphocyte,Antibodies, Lymphocytotoxic,Antibody, Antilymphocyte,Antibody, Lymphocytotoxic,Antilymphoblast Globulin,Antilymphocyte Antibody,Antilymphocyte Globulins,Antilymphocyte Immunoglobulins,Antilymphocyte Serums,Antithymocyte Globulins,Antithymoglobulins,Globulin, Anti-Thymocyte,Globulin, Antilymphoblast,Globulin, Antilymphocyte,Globulin, Antithymocyte,Globulins, Anti-Thymocyte,Globulins, Antilymphoblast,Globulins, Antilymphocyte,Globulins, Antithymocyte,Immunoglobulin, Antilymphocyte,Immunoglobulins, Antilymphocyte,Lymphocyte Immune Globulin, Anti Thymocyte Globulin,Lymphocytotoxic Antibody,Serum, Antilymphocyte,Serums, Antilymphocyte
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma

Related Publications

S Imperato, and F Manca, and A L Kunkl, and L Di Crescenzo, and A Gremmo
November 1973, Experimental cell research,
S Imperato, and F Manca, and A L Kunkl, and L Di Crescenzo, and A Gremmo
August 1975, Experimental cell research,
S Imperato, and F Manca, and A L Kunkl, and L Di Crescenzo, and A Gremmo
January 1980, Radiation and environmental biophysics,
S Imperato, and F Manca, and A L Kunkl, and L Di Crescenzo, and A Gremmo
January 1967, Archiv fur Gynakologie,
S Imperato, and F Manca, and A L Kunkl, and L Di Crescenzo, and A Gremmo
July 1988, Cancer research,
S Imperato, and F Manca, and A L Kunkl, and L Di Crescenzo, and A Gremmo
January 1966, International journal of radiation biology and related studies in physics, chemistry, and medicine,
S Imperato, and F Manca, and A L Kunkl, and L Di Crescenzo, and A Gremmo
January 1984, Eksperimental'naia onkologiia,
S Imperato, and F Manca, and A L Kunkl, and L Di Crescenzo, and A Gremmo
March 1968, Strahlentherapie,
S Imperato, and F Manca, and A L Kunkl, and L Di Crescenzo, and A Gremmo
January 1976, Comptes rendus des seances de la Societe de biologie et de ses filiales,
S Imperato, and F Manca, and A L Kunkl, and L Di Crescenzo, and A Gremmo
May 1966, Geburtshilfe und Frauenheilkunde,
Copied contents to your clipboard!